BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 30572915)

  • 1. Arsenic trioxide reverses the chemoresistance in hepatocellular carcinoma: a targeted intervention of 14-3-3η/NF-κB feedback loop.
    Qiu Y; Dai Y; Zhang C; Yang Y; Jin M; Shan W; Shen J; Lu M; Tang Z; Ju L; Wang Y; Jiao R; Xia Y; Huang G; Yang L; Li Y; Zhang J; Wong VKW; Jiang Z
    J Exp Clin Cancer Res; 2018 Dec; 37(1):321. PubMed ID: 30572915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arsenic trioxide induces differentiation of cancer stem cells in hepatocellular carcinoma through inhibition of LIF/JAK1/STAT3 and NF-kB signaling pathways synergistically.
    Zhang X; Hu B; Sun YF; Huang XW; Cheng JW; Huang A; Zeng HY; Qiu SJ; Cao Y; Fan J; Zhou J; Yang XR
    Clin Transl Med; 2021 Feb; 11(2):e335. PubMed ID: 33634982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of NF-κB in PARP-inhibitor-mediated sensitization and detoxification of arsenic trioxide in hepatocellular carcinoma cells.
    Luo Q; Li Y; Lai Y; Zhang Z
    J Toxicol Sci; 2015 Jun; 40(3):349-63. PubMed ID: 25972196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Icariin synergizes with arsenic trioxide to suppress human hepatocellular carcinoma.
    Li W; Wang M; Wang L; Ji S; Zhang J; Zhang C
    Cell Biochem Biophys; 2014 Mar; 68(2):427-36. PubMed ID: 23975599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of TGF-β/SMAD3/NF-κB signaling by microRNA-491 is involved in arsenic trioxide-induced anti-angiogenesis in hepatocellular carcinoma cells.
    Jiang F; Wang X; Liu Q; Shen J; Li Z; Li Y; Zhang J
    Toxicol Lett; 2014 Nov; 231(1):55-61. PubMed ID: 25196641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De-methylation of miR-148a by arsenic trioxide enhances sensitivity to chemotherapy via inhibiting the NF-κB pathway and CSC like properties.
    Wang Y; Jiang F; Jiao K; Ju L; Liu Q; Li Y; Miao L; Li Z
    Exp Cell Res; 2020 Jan; 386(2):111739. PubMed ID: 31759055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The lncARSR/PTEN/Akt/nuclear factor-kappa B feedback regulatory loop contributes to doxorubicin resistance in hepatocellular carcinoma.
    Li Y; Li J; Chen H; Wang J; Jiang L; Tan X
    J Biochem Mol Toxicol; 2022 Sep; 36(9):e23119. PubMed ID: 35678308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arsenic trioxide augments immunogenic cell death and induces cGAS-STING-IFN pathway activation in hepatocellular carcinoma.
    Li X; Pan YF; Chen YB; Wan QQ; Lin YK; Shang TY; Xu MY; Jiang TY; Pei MM; Tan YX; Dong LW; Wan XY
    Cell Death Dis; 2024 Apr; 15(4):300. PubMed ID: 38684648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arsenic trioxide inhibits liver cancer stem cells and metastasis by targeting SRF/MCM7 complex.
    Wang HY; Zhang B; Zhou JN; Wang DX; Xu YC; Zeng Q; Jia YL; Xi JF; Nan X; He LJ; Yue W; Pei XT
    Cell Death Dis; 2019 Jun; 10(6):453. PubMed ID: 31186405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxic Hepatocellular Carcinoma Cells Acquire Arsenic Trioxide Resistance by Upregulating HIF-1α Expression.
    Chen Y; Li H; Chen D; Jiang X; Wang W; Li D; Shan H
    Dig Dis Sci; 2022 Aug; 67(8):3806-3816. PubMed ID: 34383201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arsenic trioxide-induced upregulation of miR-1294 suppresses tumor growth in hepatocellular carcinoma by targeting TEAD1 and PIM1.
    Cai X; Yu L; Chen Z; Ye F; Ren Z; Jin P
    Cancer Biomark; 2020; 28(2):221-230. PubMed ID: 32280078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COMMD7 is correlated with a novel NF-κB positive feedback loop in hepatocellular carcinoma.
    Zheng L; Deng CL; Wang L; Huang XB; You N; Tang YC; Wu K; Liang P; Mi N; Li J
    Oncotarget; 2016 May; 7(22):32774-84. PubMed ID: 27129158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nutlin-3 overcomes arsenic trioxide resistance and tumor metastasis mediated by mutant p53 in Hepatocellular Carcinoma.
    Zheng T; Yin D; Lu Z; Wang J; Li Y; Chen X; Liang Y; Song X; Qi S; Sun B; Xie C; Meng X; Pan S; Liu J; Jiang H; Liu L
    Mol Cancer; 2014 May; 13():133. PubMed ID: 24884809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reciprocal activation between ATPase inhibitory factor 1 and NF-κB drives hepatocellular carcinoma angiogenesis and metastasis.
    Song R; Song H; Liang Y; Yin D; Zhang H; Zheng T; Wang J; Lu Z; Song X; Pei T; Qin Y; Li Y; Xie C; Sun B; Shi H; Li S; Meng X; Yang G; Pan S; Zhu J; Qi S; Jiang H; Zhang Z; Liu L
    Hepatology; 2014 Nov; 60(5):1659-73. PubMed ID: 25042864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genistein potentiates the effect of arsenic trioxide against human hepatocellular carcinoma: role of Akt and nuclear factor-κB.
    Ma Y; Wang J; Liu L; Zhu H; Chen X; Pan S; Sun X; Jiang H
    Cancer Lett; 2011 Feb; 301(1):75-84. PubMed ID: 21078540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of TG-interacting factor sensitizes arsenic trioxide-induced apoptosis in human hepatocellular carcinoma cells.
    Liu ZM; Tseng JT; Hong DY; Huang HS
    Biochem J; 2011 Sep; 438(2):349-58. PubMed ID: 21649584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shikonin potentiates the effect of arsenic trioxide against human hepatocellular carcinoma in vitro and in vivo.
    Song J; Zhao Z; Fan X; Chen M; Cheng X; Zhang D; Wu F; Ying X; Ji J
    Oncotarget; 2016 Oct; 7(43):70504-70515. PubMed ID: 27655700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.
    Ozaki I; Zhang H; Mizuta T; Ide Y; Eguchi Y; Yasutake T; Sakamaki T; Pestell RG; Yamamoto K
    Clin Cancer Res; 2007 Apr; 13(7):2236-45. PubMed ID: 17404108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RhoE/ROCK2 regulates chemoresistance through NF-κB/IL-6/ STAT3 signaling in hepatocellular carcinoma.
    Ma W; Sze KM; Chan LK; Lee JM; Wei LL; Wong CM; Lee TK; Wong CC; Ng IO
    Oncotarget; 2016 Jul; 7(27):41445-41459. PubMed ID: 27213590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of CYLD as a trigger for NF-κB activation and a mechanism of apoptotic resistance in hepatocellular carcinoma cells.
    Urbanik T; Köhler BC; Boger RJ; Wörns MA; Heeger S; Otto G; Hövelmeyer N; Galle PR; Schuchmann M; Waisman A; Schulze-Bergkamen H
    Int J Oncol; 2011 Jan; 38(1):121-31. PubMed ID: 21109933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.